Phase III study comparing pixy321 and GM-CSF following autologous bone marrow transplantation (ABMT) in patients with nonHodgkin's lymphoma (NHL)

被引：0
|
作者：
Vose, JM
Pandite, L
Beveridge, RA
Geller, RB
Schuster, MW
Anderson, JE
LeMaistre, CF
Lebsack, ME
机构：
[1] UNIV NEBRASKA, MED CTR, OMAHA, NE 68105 USA
[2] DANA FARBER CANC INST, BOSTON, MA 02115 USA
[3] CORAM, FAIRFAX HOSP, FAIRFAX HEM ONC ASSOC, FAIRFAX, VA USA
[4] EMORY UNIV, ATLANTA, GA 30322 USA
[5] N SHORE UNIV HOSP, MANHASSET, NY USA
[6] FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA
[7] S TEXAS CANC INST, SAN ANTONIO, TX USA
[8] IMMUNEX CORP, SEATTLE, WA USA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3876 / 3876
页数：1
相关论文
共 50 条
  • [1] Effects of PIXY321 (GM-CSF/IL-3 fusion protein) in pediatric patients (PTS) with bone marrow failure
    Jeha, S
    Hoots, WK
    Garrison, L
    VadhanRaj, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1032 - 1032
  • [2] Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy
    Vose, JM
    Anderson, JE
    Bierman, PJ
    Appelbaum, FR
    Anderson, JR
    Garrison, L
    Lebsack, ME
    Armitage, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 520 - 526
  • [3] STIMULATION OF HEMATOPOIESIS BY PIXY321 (GM-CSF/IL-3 FUSION PROTEIN) IN PATIENTS WITH BONE-MARROW FAILURE
    VADHANRAJ, S
    JEHA, S
    BROXMEYER, HE
    HITTELMAN, WN
    THOMPSON, P
    ARCENAS, A
    HOOTS, WK
    ESTEY, E
    GARRISON, L
    BLOOD, 1993, 82 (10) : A366 - A366
  • [4] ERYTHROPOIETIN AND GM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    PEDRAZZINI, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A : S15 - S17
  • [5] Dose escalation study of PIXY321 post autologous bone marrow transplant (BMT) for Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL).
    Nantel, SH
    Bernstein, SH
    Stevens, DA
    Fay, JW
    Herzig, RH
    Phillips, GL
    Herzig, GP
    Garrison, L
    BLOOD, 1995, 86 (10) : 876 - 876
  • [6] The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer
    Ghielmini, M
    Pettengell, R
    Coutinho, LH
    Testa, N
    Crowther, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) : 6 - 12
  • [7] EFFECTS OF IL-3, GM-CSF AND M-CSF ON MONOCYTE FUNCTION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    FABIAN, I
    SHAPIRA, E
    KLETTER, Y
    GADISH, M
    NAGLER, A
    FLIDEL, O
    SLAVIN, S
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 561 - 561
  • [8] GM-CSF mobilised peripheral blood progenitor cell transplantation (PBPCT) vs autologous bone marrow transplantation (ABMT).
    Kumar, L
    Kochupillai, V
    Raju, GMK
    Sharma, A
    Chandy, L
    BLOOD, 1996, 88 (10) : 3674 - 3674
  • [9] A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation
    SanMiguel, JF
    Hernandez, MD
    Gonzalez, M
    LopezBerges, MC
    Caballero, MD
    Vazquez, L
    Orfao, A
    Nieto, MJ
    delCanizo, MC
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (01) : 140 - 147
  • [10] BONE-MARROW BIOPSY MORPHOLOGY IN PATIENTS RECEIVING RECOMBINANT HUMAN GRANULOCYTE - MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    ATWATER, S
    BOROWITZ, M
    BRANDT, S
    OETTE, D
    PETERS, W
    LABORATORY INVESTIGATION, 1988, 58 (01) : A6 - A6
12345